“Spot-on” evidence-based urological nursing care – An overview of new research and developments

The growing evidence in urology nursing care is amazing!

With this column, the EAUN SIG Groups want to put the spotlight on recent publications in their field of interest. This month’s articles have been carefully chosen because of the scientific value from PubMed and other sources and represent different methods and approaches in research and development in urological nursing care.

We hope this initiative will have your attention and continuously provide information on “spot-on” urological nursing care. If you would like to inform us and your colleagues about new initiatives or exiting developments in one of the special interest fields you can contact us using the email addresses below.

Best regards

Anna Mohammed, Chair,
EAUN Special Interest Group – Endourology
a.mohammed@eaun.org

Bente Thoft Jensen, Chair,
EAUN Special Interest Group – Bladder Cancer
b.thoft@eaun.org

Louisa Fleure, Chair,
EAUN Special Interest Group – Prostate Cancer
l.fleure@eaun.org

Selected from Scientific Sources

Endourology

  • Lone Z, Zhang A, Benidir T, et al. The role of enhanced recovery after surgery protocols in the development of acute kidney injury following radical  cystectomy. Urol Oncol. 2022 Oct;40(10):453.e1-453.e7. doi:10.1016/j.urolonc.2022.07.004. Epub 2022 Aug 8. PMID: 35953395. https://pubmed.ncbi.nlm.nih.gov/35953395/
  • Mjaess G, Diamand R, Aoun F, et al. European Association of Urology – Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison. Eur J Surg Oncol. 2022 Aug 11:S0748-7983(22)00584-4. doi: 10.1016/j.ejso.2022.07.023. Epub ahead of print. PMID: 35970622. https://pubmed.ncbi.nlm.nih.gov/35970622/
  • Bravi CA, Paciotti M, Sarchi L, et al. Robot-assisted Radical Prostatectomy with the Novel Hugo Robotic System: Initial Experience and Optimal Surgical Set-up at a Tertiary Referral Robotic Center. Eur Urol. 2022 Aug;82(2):233-237. doi: 10.1016/j. eururo.2022.04.029. Epub 2022 May 12. PMID:35568597.
    https://pubmed.ncbi.nlm.nih.gov/35568597/
  • Harper JD, Metzler I, Hall MK, et al. First In-Human Burst Wave Lithotripsy for Kidney Stone Comminution: Initial Two Case Studies. J Endourol. 2021 Apr;35(4):506-511. doi: 10.1089/end.2020.0725. Epub 2020 Nov 5. PMID: 32940089; PMCID:PMC8080914. https://pubmed.ncbi.nlm.nih.gov/32940089/
  • Gandaglia G, Mazzone E, Stabile A, et al. Prostatespecific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study. Eur Urol. 2022 Oct;82(4):411-418. doi: 10.1016/j.eururo.2022.06.002. Epub 2022 Jul 22. PMID: 35879127. https://pubmed.ncbi.nlm.nih.gov/35879127/
  • Rai BP, Luis Dominguez Escrig J, Vale L,et al. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria. Eur Urol. 2022 Aug;82(2):182-192. doi: 10.1016/j. eururo.2022.03.027. Epub 2022 Apr 5. PMID:35393159.
    https://pubmed.ncbi.nlm.nih.gov/35393159/
  • Li J, Yang X, Chu G, et al. Application of Improved Robot-assisted Laparoscopic Telesurgery with 5G Technology in Urology. Eur Urol. 2022 Jul 8:S0302-2838(22)02469-1. doi: 10.1016/j.eururo.2022.06.018. Epub ahead of print. PMID: 35817641. https://pubmed.ncbi.nlm.nih.gov/35817641/
  • Majdalany SE, Levin BA, Ghani KR. The Efficiency of Moses Technology Holmium Laser for Treating Renal Stones During Flexible Ureteroscopy: Relationship Between Stone Volume, Time, and Energy. J Endourol. 2021 Dec;35(S3):S14-S21. doi: 10.1089/end.2021.0592. PMID: 34910609.
    https://pubmed.ncbi.nlm.nih.gov/34910609/
  • Assmus MA, Ganesh MB, Lee MS, et al. Contemporary Outcomes for Patients Undergoing Concurrent Surgeries at the Time of Holmium Laser Enucleation of the Prostate Before and After Moses 2.0 BPH Mode. J Endourol. 2021 Dec;35(S3):S8-S13. doi: 10.1089/end.2021.0531. PMID: 34910607.
    https://pubmed.ncbi.nlm.nih.gov/34910607/
  • Parkhomenko E, O’Leary M, Safiullah S, et al. Pilot Assessment of Immersive Virtual Reality Renal Models as an Educational and Preoperative Planning Tool for Percutaneous Nephrolithotomy. J Endourol. 2019 Apr;33(4):283-288. doi: 10.1089/end.2018.0626. Epub 2018 Dec 21. PMID: 30460860.
    https://pubmed.ncbi.nlm.nih.gov/30460860/

Bladder cancer

  • Saunders H, Creswell J. Recent developments in bladder cancer – NMIBC. Urology News 2022;26(4). https://www.urologynews.uk.com/features/features/post/recent-developments-in-bladdercancer-nmibc
  • Goddard JC. The bilious solution of Monsieurs Calmette et Guérin. Urology News 2022;26(5). https://www.urologynews.uk.com/features/history-of-urology/post/the-bilious-solution-ofmonsieurs-calmette-et-gu%C3%A9rin
  • Hensley PJ, Bree KK, Brooks N, et al. Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy Outcomes. Eur Urol Oncol. 2022 Jun;5(3):347-356. doi: 10.1016/j.euo.2021.04.003. Epub 2021 Apr 29. PMID: 33935020; PMCID: PMC8553807. https://pubmed.ncbi.nlm.nih.gov/33935020/
  • Tan WS, Steinberg G, Witjes JA, et al. Intermediaterisk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. Eur Urol Oncol. 2022 Oct;5(5):505-516. doi: 10.1016/j.euo.2022.05.005. Epub 2022 Jun 17. PMID: 35718695. https://pubmed.ncbi.nlm.nih.gov/35718695/
  • Ghatalia P, Plimack ER. Adding a Fourth Modality to Trimodal Therapy for Muscle-invasive Bladder Cancer. Eur Urol. 2022 Nov;82(5):527-528. doi:10.1016/j.eururo.2022.08.017. Epub 2022 Sep 2. PMID: 36064477. https://pubmed.ncbi.nlm.nih.gov/36064477/
  • Heyes SM, Prior KN, Whitehead D, Bond MJ. Toward an Understanding of Patients’ and Their Partners’ Experiences of Bladder Cancer. Cancer Nurs. 2020 Sep/Oct;43(5):E254-E263. doi: 10.1097/NCC.0000000000000718. PMID: 31033514. https://pubmed.ncbi.nlm.nih.gov/31033514/
  • Mohamed NE, Shah QN, Kata HE, et al. Dealing With the Unthinkable: Bladder and Colorectal Cancer Patients’ and Informal Caregivers’ Unmet Needs and Challenges in Life After Ostomies. Semin Oncol Nurs. 2021 Feb;37(1):151111. doi: 10.1016/j.soncn.2020.151111. Epub 2021 Jan 7. PMID:33423864 Review.
    https://pubmed.ncbi.nlm.nih.gov/33423864/
  • Gao Z, Fang L, Yin P, et al. Effects of Nursing Care for the Treatment of Patients with Bladder Cancer: A Systematic Review and Meta-analysis. Comput Math Methods Med. 2022 Sep 25;2022:9554223. doi:10.1155/2022/9554223. eCollection 2022. PMID:36199769 Free PMC article. https://pubmed.ncbi.nlm.nih.gov/36199769/
  • Heyes SM, Bond MJ. Pathways to psychological wellbeing for patients with bladder cancer and their partners-in-care. Eur J Oncol Nurs. 2020 Apr 7;46:101757. doi: 10.1016/j.ejon.2020.101757. Online ahead of print. PMID: 32353738. https://pubmed.ncbi.nlm.nih.gov/32353738/
  • Rammant E, Van Hecke A, Decaestecker K, et al. Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy: A longitudinal study. Psychooncology. 2022 Feb;31(2):219-226. doi:10.1002/pon.5795. Epub 2021 Aug 27. PMID: 34449941.
    https://pubmed.ncbi.nlm.nih.gov/34449941/

Prostate cancer

  • Power JW, Ryan JW, Hutchinson B, et al. Change from transrectal to transperineal ultrasound-guided prostate biopsy under local anaesthetic eliminates sepsis as a complication. J Hosp Infect. 2022 Jul;125:44-47. doi:10.1016/j.jhin.2022.03.009. Epub 2022 Apr 4. PMID:35390395. https://pubmed.ncbi.nlm.nih.gov/35390395/
  • Siltari A, Riikonen J, Koskimäki J, et al. Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol. BMJ Open. 2022 Apr 29;12(4):e050264. doi:10.1136/bmjopen-2021-050264. PMID: 35487730; PMCID: PMC9058683. https://pubmed.ncbi.nlm.nih.gov/35487730/
  • Beckmann, K, Cahill, D, Brown, C, et al. Developing a consensus statement for psychosocial support in active surveillance for prostate cancer. BJUI Compass. 2022. https://doi.org/10.1002/bco2.155/.
  • Greenwood-Wilson, S., Bridge, P. Adequacy of sexual care information given to prostate cancer patients receiving radical external beam radiotherapy. Journal of Radiotherapy in Practice 2022:1-8. doi:10.1017/S1460396922000310
  • Søndergaard, M.E.J., Lode, K., Husebø, S.E. et al. Men’s perception of information and psychological distress in the diagnostic phase of prostate cancer: a comparative mixed methods study. BMC Nurs 2022;21:266 (2022). https://doi.org/10.1186/s12912-022-01047-1. https://pubmed.ncbi.nlm.nih.gov/36180907/
  • Rogers F, Rashidi A, Ewens B. Education and support for erectile dysfunction and penile rehabilitation post prostatectomy: A qualitative systematic review. Int J Nurs Stud. 2022 Jun;130:104212. doi: 10.1016/j.ijnurstu.2022.104212. Epub 2022 Feb 25. https://pubmed.ncbi.nlm.nih.gov/35395575/
  • Cope DG. Nursing Considerations for Androgen Deprivation Therapy and Bone Health in Men Affected by Prostate Cancer. Semin Oncol Nurs. 2022 Apr;38(2):151271. doi: 10.1016/j.soncn.2022.151271. Epub 2022 Apr 28. https://pubmed.ncbi.nlm.nih.gov/35491331/
  • Smith MR, Hussain M, Saad F, et al. Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial. Future Oncol. 2022 Jul;18(21):2585-2597. doi: 10.2217/fon-2022-0433. Epub 2022 Jun 3.
    https://pubmed.ncbi.nlm.nih.gov/35656777/
  • Stainer, V., Skews, R. and Aning, J.J. (2022). Managing erectile dysfunction after prostate cancer treatment. Prescriber, 33: 10-14. https://doi.org/10.1002/psb.1960
  • Kwon M, Dickerson SS, Wilding GE, et al. A nurse-delivered intervention to reduce insomnia in cancer survivors: Study protocol for a randomized controlled trial. Contemp Clin Trials. 2022 Nov;122:106939. doi: 10.1016/j.cct.2022.106939. Epub 2022 Sep 28. https://pubmed.ncbi.nlm.nih.gov/36182027/
  • Achard V, Putora PM, Omlin A, et al. Metastatic Prostate Cancer: Treatment Options. Oncology. 2022;100(1):48-59. doi: 10.1159/000519861. Epub 2021 Nov 15. https://pubmed.ncbi.nlm.nih.gov/34781285/